You are here

  • Home
  • Archive
  • Volume 29, Issue Suppl 4
  • EP635 Minimizing the dose of oral megestrol in combination with the levonorgestrel-releasing intrauterine device: an equally effective approach for the conservative management of atypical hyperplasia and well differentiated endometrial carcinoma

Article info

Article menu
Download PDFPDF
ePoster
EP635 Minimizing the dose of oral megestrol in combination with the levonorgestrel-releasing intrauterine device: an equally effective approach for the conservative management of atypical hyperplasia and well differentiated endometrial carcinoma

Authors

Citation

Haidopoulos D, Rountis A, Pergialiotis V, et al
EP635 Minimizing the dose of oral megestrol in combination with the levonorgestrel-releasing intrauterine device: an equally effective approach for the conservative management of atypical hyperplasia and well differentiated endometrial carcinoma
International Journal of Gynecologic Cancer 2019;29:A370.

Publication history

  • First published November 1, 2019.
Online issue publication 
March 03, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.